Advertisement

Topics

FDA Approval of Glatopa as Generic Option for Relapsing MS

11:47 EST 15 Feb 2018 | Drug Discovery Development

Sandoz, a Novartis division, announced the FDA approval and launch of Glatopa (glatiramer acetate injection) 40 mg/mL.
Contributed Author: 
Topics: 

Original Article: FDA Approval of Glatopa as Generic Option for Relapsing MS

NEXT ARTICLE

More From BioPortfolio on "FDA Approval of Glatopa as Generic Option for Relapsing MS"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...